Significant Ownership of Leonite Fund I, LP
- Signature - Title
- Avi Geller - Chief Investment Officer
- Location
- Spring Valley, NY
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Leonite Fund I, LP.
Follow Filing Activity
Follow Leonite Fund I, LP and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Leonite Fund I, LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| RSLS | ReShape Lifesciences Inc. | Common Shares, $0.001 par value per share | 6.1% | $76,000 | 200,000 | Leonite Fund I, LP | 18 Feb 2025 | ||
| HSDT | HELIUS MEDICAL TECHNOLOGIES, INC. | Common Shares, $0.001 par value per share | 5.2% | $699,506 | 163,055 | Leonite Fund I, LP | 05 Jun 2025 |
Schedules 13D/G Reported by Leonite Fund I, LP:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.